| Bioactivity | AN-019 is a Bcr-Abl kinase inhibitor. AN-019 has antitumor activity[1]. |
| CAS | 879507-25-2 |
| Formula | C25H17F6N5O |
| Molar Mass | 517.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Amala K, et al. Design, synthesis and preclinical evaluation of NRC-AN-019. Int J Oncol. 2013 Jan;42(1):168-78 |